Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy is a research paper published in Pharmaceutics (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley
Grant: CA210192
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley
Grant: CA206069
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley
Grant: SC1GM139727
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley
Grant: RP210180
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley
Grant: RP230419
NCI NIH HHS
Grant: R01 CA210192
NIH HHS
Grant: CA210192, CA206069, and GM139727
NCI NIH HHS
Grant: R01 CA206069
National Institutes of Health
Grant: 1R01CA206069-01A1
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
National Institutes of Health
Grant: 7R01CA210192-05
Targeted Nanotherapy for Pancreatic Cancer
National Institutes of Health
Grant: 5SC1GM139727-02
miR-205 Nanoparticle system circumvents docetaxel resistance in prostate cancer
FWCI
0.88
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords